• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Acute viral hepatitis and hepatitis B virus markers in chronic liver disease and primary cancer of the liver].

作者信息

Sebti M F

出版信息

IARC Sci Publ. 1984(63):227-36.

PMID:6100271
Abstract

A clinical and etiological study of 171 cases of acute hepatitis in subjects over 15 years of age showed that 73.7% were of the B type and 25.7% of the non-A, non-B type. A single case of hepatitis A was seen. Hepatitis B and non-A, non-B affect equally young men and women (mean age, 29 and 28, respectively), and infection occurs, for both types of hepatitis, by the parenteral route. More than 90% of cases recovered completely. The search for markers of hepatitis B virus in subjects with chronic liver diseases has shown that the B virus plays an important role in these diseases in Morocco: 6.7% of controls, 38.5% of cirrhotics and 40.9% of patients with chronic hepatitis were carriers of HBsAg. The anti-hepatitis Bc antibody was present in 53.3% of the control population, in 86.5% of cirrhotics and 90.9% of active chronic hepatitis patients. Hepatocellular carcinoma is relatively rare in Morocco, representing 5.9% of hepatic tumours and accounting for one hospitalization out of 84. It occurs in older subjects (mean age, 58 years) and more often in men than in women (40:23). The presence of HBsAg was investigated in 46 patients and 379 controls: it was found in 17% of hepatocellular carcinoma patients and 4.7% of controls. Anti-HBc antibodies were present in 76.8% of patients and 53.3% of controls.

摘要

相似文献

1
[Acute viral hepatitis and hepatitis B virus markers in chronic liver disease and primary cancer of the liver].
IARC Sci Publ. 1984(63):227-36.
2
Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.抗乙型肝炎核心免疫球蛋白M在乙型肝炎病毒感染以及与丁型肝炎病毒、非甲非乙型肝炎病毒同时感染的血清学评估中的应用
Gastroenterology. 1983 Jul;85(1):163-7.
3
[The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].[抗-HBc及隐匿性乙型肝炎病毒感染在HBsAg和抗-HCV阴性酒精性肝硬化患者肝细胞癌发生中的意义]
Korean J Hepatol. 2008 Mar;14(1):67-76. doi: 10.3350/kjhep.2008.14.1.67.
4
[Hepatocellular carcinoma (CHC) in patients chronically infected with HBV].慢性乙肝病毒感染患者的肝细胞癌(CHC)
Przegl Epidemiol. 1991;45(4):279-85.
5
Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.肝细胞癌和慢性肝病中HBV与HCV感染的比较分析——一项基于尸检的研究
Indian J Pathol Microbiol. 2006 Jul;49(3):357-61.
6
Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.新加坡原发性肝细胞癌患者中乙型和丙型肝炎病毒标志物的血清流行率。
Singapore Med J. 1996 Oct;37(5):492-6.
7
Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis.非甲非乙型输血后肝炎所致肝细胞癌
Am J Gastroenterol. 1984 Oct;79(10):777-81.
8
[Primary liver carcinoma and markers of virus of type B hepatitis (author's transl)].原发性肝癌与乙型肝炎病毒标志物(作者译)
Med Clin (Barc). 1980 Jun 25;75(2):58-60.
9
HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.丙型肝炎病毒相关肝细胞癌中的乙肝表面抗原阴性乙肝病毒感染
J Viral Hepat. 2005 May;12(3):325-9. doi: 10.1111/j.1365-2893.2005.00586.x.
10
[Markers of the hepatitis B virus and chronic alcoholism. Prevalence and risk factors].[乙肝病毒与慢性酒精中毒的标志物。患病率及危险因素]
Ann Gastroenterol Hepatol (Paris). 1991 Jan-Feb;27(1):7-12.

引用本文的文献

1
Variability in the precore and core promoter regions of HBV strains in Morocco: characterization and impact on liver disease progression.摩洛哥 HBV 株前核心和核心启动子区的变异性:特征及其对肝病进展的影响。
PLoS One. 2012;7(8):e42891. doi: 10.1371/journal.pone.0042891. Epub 2012 Aug 14.
2
First multicenter study for risk factors for hepatocellular carcinoma development in North Africa.关于北非肝细胞癌发生风险因素的首个多中心研究。
World J Hepatol. 2011 Jan 27;3(1):24-30. doi: 10.4254/wjh.v3.i1.24.